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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. D Psicose is a rare sugar present in small quantities in natural
products. In a previous study, we showed that D psicose suppresses
increase in plasma glucose and reduces body fat accumulation in
rats. Based on acute toxicity testing in rats, D psicose is classified
as an ordinary substance (LD50 = 16 g/kg). Elucidating the effects
of sub chronic feeding of D psicose in rats is essential before it can
be utilized as a physiologically functional food. In this study, male
Wistar rats (3 weeks old) were fed diets containing 3% D psicose
or sucrose for 90 days. The body weight gain and intra abdominal
adipose tissue weight did not differ between the sucrose and the
D psicose groups. The weights of the liver and kidneys were signifi 
cantly higher in the D psicose group than in the sucrose group.
However, no gross pathological findings were evident at dietary
doses of 3% D psicose or were correlated with hypertrophy of the
liver and kidney. In a clinical chemistry analysis, the erythrocyte
and leukocyte courts were significantly higher in the D psicose
group, but that was not considered to be toxicologically signifi 
cant. Therefore, the present study found no adverse effects of D 
psicose in rats fed a diet containing 3% D psicosefor 90 days.
Key Words: D psicose, sucrose, 90 day oral toxicity, 
pathological tests, rat
Introduction -Psicose (D-ribo-2-hexulose), a C-3 epimer of D-fructose, is a
“rare sugar” present in small quantities in commercial mix-
tures of D-glucose and D-fructose obtained from hydrolysis of
sucrose or isomerization of D-glucose.(1) D-Psicose is also present
in processed cane and beet molasses,(2) and is found in wheat,(3)
Itea plants,(4) and in the antibiotic psicofranine.(5) Examining the
effects of D-psicose on glucose and lipid metabolism, we found
that D-psicose is a sweet monosaccharaide that provides no energy
to growing rats and leads to less intra-abdominal fat accumulation
than  D-glucose and D-fructose in rats.(6,7) In addition, we have
suggested that supplemental D-psicose can lower plasma glucose
levels.(8) Toyoda et al.(9) suggested that D-psicose can prevent
postprandial hyperglycemia by improving the translocation of
glucokinase from nucleus to cytoplasm in the liver of diabetic rats.
D-Psicose is expected to have a beneficial effect in the control of
blood glucose levels in type 2 diabetes.
Based on acute toxicity testing in rats, D-psicose is classified as
an ordinary substance; the oral LD50 value was 16 g/kg in male
Wistar rats.(10) D-Psicose, which is naturally present in foods such
as fruit juice and fruit cereal, is derived from D-fructose by the
cooking process.(2,11) Oshima et al.(12) reported that in high-sugar
food products, heat processing had a marked effect on the produc-
tion of D-psicose. In particular, confectionery products and
seasoning sauces exhibited higher D-psicose content (0.005–
1.3 mg/g) than other products.(12) As a result, most humans ingest
a limited amount of D-psicose on a daily basis. Recently, we
examined the effects of long-term feeding (12–18 months) of D-
psicose to rats prior its utilization as a physiologically functional
food.(13) We have concluded that 3% D-psicose in the diet had no
adverse effects in rats. However, in the previous 12-to-18-month
toxicity study, because the effects of aging were strongly seen in
rats, the toxicity of D-psicose may have been hidden. Therefore, an
additional sub-chronic examination was necessary.
In this study, to assess the safety of D-psicose, 90-day oral
toxicity studies were conducted with rats at dietary dose of 3% D-
psicose. The objective was to determine whether D-psicose can be
safety used as a functional food.
Materials and Methods
All procedures involving animals were approved by the Animal
Care Committee of Kagawa University (No.19, 2010).
Animals and experimental diets. Twenty male Wistar rats
(3 weeks old) were obtained from Japan SLC (Shizuoka, Japan).
They were fed CE-2, a commercial rodent diet (CLEA, Tokyo,
Japan) and water ad libitum until they were 4 weeks old. They
were caged individually at 22 ± 2°C, with light from 08:00 to
20:00 h. The rats were randomly divided into two groups of 10
(sucrose and D-psicose groups). We adopted sucrose as a control
for D-psicose because sucrose is a very popular sweet carbohydrate
and is used in many studies as a control saccharide.(14–16) The
experimental diets were 3% sucrose or D-psicose added to CE-2.
The amount of test carbohydrates (3%) was determined with
reference to previous studies concerning D-psicose(13) or sucralose,
which has an LD50 that is the same as that of D-psicose (16 g/kg
weight).(17,18) Each group of rats was given free access to food and
water for 90 days. D-Psicose, which was made from high fructose
corn syrup by the alkaline isomerization method, was donated by
Rare Sugar Production Thecnical Research Laboratories, LLC
(Kagawa, Japan). The high fructose corn syrup used as a raw
material was supplied by Matsutani Chemical Industry, Co., Ltd.
(Hyogo, Japan). Sucrose was purchased from Wako Pure Chem.
Ind. (Osaka, Japan).
Experimental design. After 90 days of feeding, rats in each
group were fasted for 4.5 h beginning at 06:00 h, and then were
anesthetized via the intraperitoneal administration of sodium
pentobarbital. Blood was collected from the abdominal aorta for
clinical hematological analysis and to obtain serum for the
chemical analysis. The rats were allowed to exsanguinate. The
brain, heart, lungs, liver, pancreas, kidneys, adrenal glands, spleen,
testicles, intra-abdominal adipose tissues (epididymal, perirenal
and mesenteric) and muscle tissues (soleus, gastrocnemius and
plantarius) were quickly removed and weighed. Parts of the liver,
kidneys and small intestine (about 5 mm of the end of the jejunum)
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were preserved in 10% neutral buffered formalin for histopatho-
logical examinations. The stomach, small intestine, large intestine,
and cecum were also quickly removed and weighed. In addition,
the small and large intestine length, surface area and cecal content
weight were measured.
Analysis. The following hematological and clinical chemistry
parameters were evaluated WBC, RBC, Hb, Ht, MCV, MCH,
MCHC, PLT, TP, A/G, ALUB, GLO, AST, UA, BUN, CREA, Ca,
Fe, CHO, TG, GLU, and FFA. The hematological and chemical
analyses were performed by Shikokuchuken Co., Ltd. (Kagawa,
Japan). The histopathological examinations were performed by
Shikoku Cytopathology Center Co., Ltd. (Kagawa, Japan). The
fixed tissue samples from the liver, kidney and small intestine
were embedded in paraffin and cut with a microtome set at a
thickness of 5–6 µm. The tissue sections were stained with hema-
toxylin and eosin (HE) and examined with a light microscope.
Next, the histopathological findings in each rat were subjectively
quantified as follows: –, 0; ±, 1; +, 2; ++, 3; +++, 4.
Statistical analysis. All values were expressed as the
mean ± SD. The statistical analysis of the differences between the
sucrose and D-psicose groups was performed using Student’s t test.
Statistical significance was set at p value of <0.05. All analyses
were performed with a commercially available statistical software
package (Excel Statistics 2008, SSRI, Co., Ltd.).
Results
Body and tissue weights, food intake and digestive tract
size. Results for the body and tissue weights, food intake and
digestive tract size in rats fed the two substances for 90 days are
presented in Table 1. The final body weight, weight gain and food
intake did not differ between the sucrose group and the D-psicose
group. Rats actually ingested 1.67 g/kg body weight per day D-
psicose or 1.65 g/kg body weight per day of sucrose (mean values
for 90 days). The mean liver and kidney weights were signifi-
cantly higher in the D-psicose group than in the sucrose group, but
no differences were observed in any other tissues.
Serum chemical and blood hematological values. The 
serum chemical and blood hematology results for the rats are
presented in Table 2. The TP and ALBU values were significantly
higher, and the UA concentration was significantly lower in the D-
psicose group than in the sucrose group, but no differences were
observed in any other serum chemistry values between the sucrose
and  D-psicose groups. The WBC, RBC, MCHC and PLT were
significantly higher, and the MCV and MCH were significantly
lower, in the D-psicose group than in the sucrose group. No
differences were observed in the Hb concentration and Ht value
between the two dietary groups.
Histopathological examination. The histopathological ob-
servations of the liver, kidney and small intestine are presented in
Table 3. Age-related naturally-occurring lesions were observed in
the tissues, but no abnormalities due to the ingestion of D-psicose
were observed. The histopathological examination showed no
differences in the total damage in the liver, kidneys and small
intestine between the sucrose and the D-psicose groups.
Discussion
In the present 90-day feeding study of D-psicose at the dose of
3.0% in male Wistar rats, no mortality occurred, and systemic
toxicity was not evident. Although the present study demonstrated
that long-term administration of 3% D-psicose to rats led to
increases in the weights of the liver and kidneys, chemical and
histopathological examinations revealed no values suggestive of
any overt D-psicose treatment-related toxicity.
Previous testing found that the LD50 value of D-psicose
administered orally to rats was 16 g/kg.(10) In the present study, rats
actually ingested 1.67 g/kg body weight per day of D-psicose or
1.65 g/kg body weight per day of sucrose. The body weight gain
and intra-abdominal adipose tissue weight in rats did not differ
between the two dietary groups.
We previously reported that D-psicose supplements suppress
Table 1. Body weight, food intake and tissue size
Values are means ± SD for 10 rats. *Significant difference from the Sucrose group (p<0.05, Student’s
t test). 1Total weight of epididymal, perirenal and mesenteric adipose tissues. 2Total weight of soleus,
gastrocnemius and plantaris muscles.
Groups Sucrose D Psicose
Initial weight (g) 59 ± 45 9 ± 4
Final weight (g) 343 ± 24 346 ± 29
Weight gain (g) 284 ± 20 287 ± 27
Food intake (g/day) 18.9 ± 0.6 19.3 ± 1.1
Tissue weights
Brain (g) 1.73 ± 0.21 1.77 ± 0.16
Heart (g) 0.80 ± 0.05 0.79 ± 0.04
Lungs (g) 0.99 ± 0.04 0.99 ± 0.07
Liver (g) 8.98 ± 0.92 10.1 ± 1.26*
Pancreas (g) 0.43 ± 0.07 0.43 ± 0.09
Kidneys (g) 2.01 ± 0.13 2.30 ± 0.18*
Adrenals (g) 0.05 ± 0.01 0.05 ± 0.01
Spleen (g) 0.70 ± 0.08 0.69 ± 0.08
Testicles (g) 2.98 ± 0.09 3.01 ± 0.16
Intra adipose tissues1 (g) 21.0 ± 3.89 19.9 ± 2.53
Muscle tissues2 (g) 3.95 ± 0.25 3.88 ± 0.25
Intestinal tracts size
Small intestine weight (g) 5.13 ± 0.60 5.21 ± 0.49
length (m) 1.02 ± 0.06 1.04 ± 0.04
Large intestine weight (g) 1.07 ± 0.14 1.19 ± 0.16
length (×10−2·m) 18.4 ± 1.97 19.6 ± 1.90
Cecum content (g) 3.80 ± 1.07 4.13 ± 0.57
weight (g) 0.75 ± 0.12 0.78 ± 0.10
 surface  area (×103·mm 2) 3.60 ± 0.31 3.54 ± 0.15doi: 10.3164/jcbn.11 66
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hepatic lipogenic enzyme activity and reduce intra-abdominal fat
accumulation more effectively than D-glucose or D-fructose supple-
ments in rats.(7,19) In addition, we found that D-psicose is a sweet
monosaccharide that provides no energy to growing rats.(6) The
present findings did not support our previous results. However,
another our study demonstrated that rats fed a 3% D-psicose diet
for 12 months did not differ in most of the parameters from rats fed
3% sucrose, which indicates that D-psicose did not inhibit rat
growth.(13) Therefore, low dietary levels (3% of diet or less) of D-
psicose over an extended period primarily affected fat accumula-
tion, with either no effects or only minimal effects on other organs.
In a previous short-term toxicity test in rats, we showed that the
feeding of diets with extremely high levels of D-psicose appeared
to be harmful to the intestinal tract.(10,20) Moreover, we previously
reported that the cecal weight, cecal surface area and cecal content
weight increased with increases of D-psicose in the diet (above
10%).(10,20) D-Psicose is partly absorbed in the digestive tract and is
excreted into the urine and feces. However, it is also fermented in
the cecum by intestinal microflora, producing short-chain fatty
acids as soluble dietary fiber.(21,22) In this study, no adverse effects
on the intestinal tract were seen when the rats were fed 3% D-
psicose in the diet. Therefore, 3% D-psicose in the diet does not
appear to be harmful to the intestinal tract.
Dietary D-psicose increased the weights of the animal’s liver
(12% lager than the sucrose group) and kidneys (14% lager). This
finding agrees with our previous studies.(7,8,10,13) The serum level of
AST is used as an index of hepatic damage. These values in this
study did not differ between the D-psicose and sucrose groups. In
addition, histopathological observations of the liver and kidneys
revealed no abnormalities due to the ingestion of D-psicose. Liver
enlargement occurs in animals and humans under a variety of
conditions, with different consequences for health.(23) For example,
it can be the result of a physiological adaptation to an enhanced
workload or metabolic demand, metabolic abnormalities, toxicity,
an inflammatory process, or due to proliferative disease.(24–26) Bar
et al.(27) found that D-tagatose, another rare sugar, increased
liver glycogen deposition and relative liver weights in non-fasting
rats at dietary levels of 5–20%. D-Tagatose is an incompletely
absorbed ketohexose that has potential as an energy-reduced
alternative sweetener. They concluded that the liver enlargement
seen in response to the consumption of D-tagatose was a physio-
logical response to the treatment-induced increase in glycogen
deposition. We previously found that D-psicose treatment induced
an increase in glycogen deposition.(8) In addition, it was reported
that D-psicose could increase the glucokinase activity by enhancing
the translocation of glucokinase from the nucleus to the cytoplasm
in the liver of diabetic rats.(9) However, it is unknown whether
these mechanisms of liver enlargement induced by D-psicose and
D-tagatose are the same.
Glycogen deposition and liver enlargement (increased relative
Table 2. Serum chemical and blood hematological test results
Values are means ± SD for 10 rats. *Significant difference from the
Sucrose group (p<0.05, Student’s t test).
Groups Sucrose D Psicose
Serum
TP (g/100 ml) 6.01 ± 0.12 6.22 ± 0.22*
A/G 3.39 ± 0.39 3.37 ± 0.27
ALBU (g/100 ml) 4.63 ± 0.13 4.79 ± 0.15*
GLO (g/100 ml) 1.38 ± 0.13 1.43 ± 0.12
AST (IU/l) 161 ± 29 167 ± 47
UA (mg/100 ml) 1.06 ± 0.16 0.81 ± 0.07*
BUN (mg/100 ml) 18.3 ± 3.6 20.5 ± 1.9
CREA (mg/100 ml) 0.32 ± 0.02 0.30 ± 0.07
Ca (mg/100 ml) 10.0 ± 0.1 10.3 ± 0.2
Fe (μg/100 ml) 119 ± 19 107 ± 16
CHO (mg/100 ml) 63.0 ± 11.8 65.1 ± 13.1
TG (mg/100 ml) 42.2 ± 21.9 68.1 ± 28.0
GLU (mg/100 ml) 142 ± 17 173 ± 18
FFA (mEq/100 ml) 0.67 ± 0.15 0.69 ± 0.10
Blood
WBC (×102/μl) 30.9 ± 5.4 44.4 ± 3.7*
RBC (×104/μl) 896 ± 27 936 ± 28*
Hb (g/100 ml) 15.3 ± 0.3 15.3 ± 0.3
Ht (%) 45.6 ± 0.8 45.0 ± 0.9
MCV (fl) 51.0 ± 1.4 48.2 ± 0.8*
MCH (pg) 17.1 ± 0.4 16.3 ± 0.2*
MCHC (%) 33.5 ± 0.4 33.9 ± 0.4*
PLT (×104/μl) 64.7 ± 6.3 71.8 ± 6.3*
Table 3. Histopathological observations of liver, kidney and small intestine1
Values are means ± SD for 10 rats. 1Quantify the findings level of damage in each rat; –, 0; ±, 1; +, 2; ++, 3; +++, 4.
Groups Sucrose D Psicose
Organs Findings
Liver Bile duct proliferation 0.1 ± 0.3 0.0 ± 0.0
Necrosis 0.4 ± 0.5 0.3 ± 0.5
Microgranuloma 0.7 ± 0.5 1.0 ± 0.8
Lipid deposition 0.3 ± 0.5 0.0 ± 0.0
Fatty change 0.1 ± 0.3 0.0 ± 0.0
Total score of damage 1.6 ± 1.2 1.3 ± 0.8
Kidney Basophilic change in the tubule 1.1 ± 0.9 1.1 ± 1.0
Hyaline cast in the tubule 0.0 ± 0.0 0.4 ± 0.8
Brown pigment deposition in the tubule 0.0 ± 0.0 0.0 ± 0.0
Atrophy of the glomerulus 0.0 ± 0.0 0.0 ± 0.0
Hyalinization in the glomerulus 0.0 ± 0.0 0.0 ± 0.0
Thickening of Bowman’s capsule basement membrane 0.0 ± 0.0 0.0 ± 0.0
Lymphocyte infiltration in the interstitium 0.4 ± 0.5 0.5 ± 0.7
Total score of damage 1.5 ± 1.3 2.0 ± 1.5
Small intestine Villous damage 1.1 ± 1.0 1.1 ± 1.0
Crypt damage 0.1 ± 0.3 0.0 ± 0.0
Cellular infiltration 0.8 ± 0.6 1.2 ± 1.0
Goblet cell depletion 0.2 ± 0.6 0.0 ± 0.0
Total score of damage 2.2 ± 2.3 2.3 ± 1.9 J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 161
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liver weights) were also seen in rats fed diets with high levels of
various other accharides.(28–30) It was hypothesized that the forma-
tion of phosphorylated metabolites plays a crucial role in this
process, either by activating glucokinase or by changing the
intracellular concentrations of phosphate compounds.(9) It is
possible that D-psicose, of which about 50% is absorbed,(21) is
more active than D-fructose in promoting glycogen deposition.
The slower degradation of psicose-1-phosphate may account for
this phenomenon.
In the hematological analysis performed as part of this study,
dietary D-psicose significantly increased the WBC, RBC and PLT
values compared to sucrose, and significantly decreased the MCV
and MCH values. However, these values remained within the
normal rage, indicating that there was no overt D-psicose toxicity.
In conclusion, the present study evaluated the effects of 90-day
3%  D-psicose administration to rats, and found that there were
to be increases in the liver and kidney weights, with no gross
pathological findings associated with this hypertrophy. The
hematological and chemical values were not suggestive of any
overt D-psicose toxicity. Overall, no adverse effects were seen at
this low dose level of D-psicose in the diet.
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A/G ratio of albumin and globulin
ALBU albumin
AST aspartate aminotransferase
BUN urea nitrogen
Ca calcium
CHO total cholesterol
CREA creatinine
Fe iron
FFA free fatty acid
GLO globulin
GLU glucose
Hb hemoglobin
HCT hematocrit
MCV mean corpuscular volume
MCH mean corpuscular hemoglobin
MCHC mean corpuscular hemoglobin concentration
PLT platelet count
RBC erythrocyte count
TG triglycerides
TP total protein
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